What we do
Atley develops technology for the scalable production of At-211 labeled radiopharmaceuticals. This technology is already enabling the development of new, efficient, and less toxic treatments for disseminated cancer.
Our technology offering spanns the At-211 radiopharmaceutical value chain and is centered around our flagship product: the Atley C100. This product is used to manufacture At-211-based radiopharmaceuticals in a scalable and reproducible manner, and is a pre-requisite for larger clinical trials and commercial roll out of such drug products.
Our product development requires a skilled and cross-functional team, blending mechanical engineering, material sciences, chemistry, software, electrical and electronic engineering, and beyond.
No jobs found
Your search does not match any job. Connect with us to stay up-to-date on new openings.